WISN Milwaukee on MSN1h
Health department responds to Hepatitis A exposure at Milwaukee's Beans & Barley
A Beans & Barley employee tested positive for Hepatitis A, prompting a public health response from the City of Milwaukee ...
KTNV Las Vegas, NV on MSN1d
Here are some tips to prevent getting norovirus as SNHD reports increase
Norovirus cases typically increase between November and April. Common symptoms include diarrhea, vomiting, nausea, stomach pain, fever, chills, headache, muscle aches and fatigue.
KSL1d
Are Ozempic weight loss shots worth side effects? Do better options exist?
"I have seen side effects last long after patients discontinue the shots. These have included nausea, gastroparesis, bloating, fatigue, burping, stomach pain and weight gain." Roberts cites an article ...
The RiotACT2h
Testing times mean hep C could be eliminated in the ACT
“Hep C is not this big, scary thing anymore. There’s a quick test. There’s a quick treatment – a few pills over eight to 12 ...
Uptick in norovirus reported around Las Vegas
Health officials are advising the community of an uptick in norovirus observed in the Las Vegas area.The Southern Nevada ...
5 of the top sources of foodborne illness and how to prevent it
Amid the ongoing McDonald's E. coli investigation, Fox News Digital spoke with several food safety experts about the most ...
manilatimes3d
Iqirvo® (elafibranor) data shows efficacy and safety for up to 3 years in patients with PBC with improvements in fatigue and pruritus
No new safety findings were observed. The most common treatment-emergent adverse events (>10 percent) occurring more ...
'I have terminal lung cancer – I ignored one giveaway sign for years that you should always check'
A woman who was diagnosed with stage 4 terminal lung cancer at the age of 34 has opened up about the five symptoms she ...
PharmiWeb9h
Iqirvo® (elafibranor) data show efficacy and tolerability for up to 3 years in patients with PBC with improvements in fatigue and pruritus
Ipsen presents three late-breaking presentations and eight abstracts across rare cholestatic liver disease portfolio at AASLD 2024Elafibranor was granted marketing authorisation for the treatment of ...
Rolling Out3d
Recognizing subtle signs of pancreatic cancer
Pancreatic cancer develops quietly, with symptoms that may seem insignificant at first glance. This cancer affects the ...
Ipsen Pharma: Iqirvo (elafibranor) data shows efficacy and safety for up to 3 years in patients with PBC with improvements in fatigue and pruritus
Ipsen presents 3 late-breaking presentations and 8 abstracts across rare cholestatic liver disease portfolio at AASLD 2024Iqirvo approved for use in the U.S. in June 2024, in the E.U. in September 202 ...